• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Compass Therapeutics Inc (NQ: CMPX )

    1.900 +0.100 (+5.56%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Compass Therapeutics Inc

    < Previous 1 2 3 Next >
    CMPX Stock Earnings: Compass Therapeutics Meets EPS for Q2 2024
    CMPX stock results show that Compass Therapeutics met analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    CMPX Stock Earnings: Compass Therapeutics Beats EPS for Q1 2024
    CMPX stock results show that Compass Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Recap: Compass Therapeutics Q3 Earnings
    Via Benzinga
    Compass Therapeutics: Q1 Earnings Insights
    Via Benzinga
    Expert Ratings for Compass Therapeutics
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    3 Penny Stocks With the Power to 10X Your $1K Investment
    The 10X penny stocks discussed here are a much more reliable investment than many other alternatives investors are likely to encounter. 
    Via InvestorPlace
    CMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023
    CMPX stock results show that Compass Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition
    These are the healthcare stocks to buy as they represent companies investing in research and development for growth and value creation. 
    Via InvestorPlace
    Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
    Via Benzinga
    Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in... 
    Via Benzinga
    Dow Drops 100 Points; Verizon Issues Weak Earnings Forecast
    U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.31% to 33,524.12 while the NASDAQ fell... 
    Via Benzinga
    Compass Therapeutics' Combo Therapy Shows Around 38% Overall Response Rate In Pretreated Biliary Tract Cancer Patients
    Compass Therapeutics Inc (NASDAQ: CMPX) announced the presentation of data from a Phase 2 study of CTX-009 in combination with paclitaxel in patients with biliary tract cancers (BTC). 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
    Via Benzinga
    Top Cheap Stocks: Trading Opportunities For Next Week - Sunday, Nov. 13
    A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Here is a closer look at some cheap stock opportunities that... 
    Via Talk Markets
    Executives Buy Around $9M Of 4 Penny Stocks
    The Nasdaq Composite index jumped by more than 300 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence... 
    Via Benzinga
    Executives Buy Around $4M Of 5 Penny Stocks
    US stock futures traded slightly lower this morning on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.